fashion -WSS

fashion

author：knowledge 2025-09-29 20:52:36 - browse：13199

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Bacterial infection may be ‘key event’ in endometriosis, study says

leisure time

WSS

Updated Covid vaccine has 54% effectiveness, new study suggests

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

340B reform proposal comes out of Senate working group

Bernie brings in new pharma CEOs to talk drug prices

The CDC's new social media misinformation war

Why CTE doesn’t keep Americans from enjoying the Super Bowl

explore

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Australia's humpback populations rebound raising hopes of marine scientists

Supreme Court strikes down use of affirmative action

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

At least 13 dead in Texas as scorching temps continue

Grail is spending more than ever lobbying Congress

New air purifier tech could be key to improving indoor air quality

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

What does generative AI mean for health care? We asked experts

Readout LOUD: Venture capital, Gilead, and more M&A

entertainment

Top private equity targets in 2023: cardiology, clinical trials, lasers

Doctor appointment wait times are getting worse

The Biogen Aduhelm mess could happen again

Pfizer's Covid pill remains 89% effective in final analysis, company says

Option Care buys Amedisys in $3.6 billion home care deal

Readout Newsletter: Amgen, Regeneron, BGI Group and more

hotspot

Wikipedia

leisure time

hotspot